{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T16:27:37Z","timestamp":1794587257405,"version":"4.9.1"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"25","license":[{"start":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T00:00:00Z","timestamp":1781827200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,6,19]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>\n                      Poor glycemic control in type 2 diabetes mellitus (T2DM) is frequently associated with adverse lipid profiles, including elevated triglycerides (TG) and low high-density lipoprotein cholesterol (HDL-C). Lipid ratios, including TG\/HDL-C (triglycerides\/high-density lipoprotein cholesterol) and LDL-C\/HDL-C (low-density\/ high-density lipoprotein cholesterol), may serve as simple markers of insulin resistance and cardiometabolic risk. This study aimed to investigate the association between glycemic control and lipid parameters, including TG, HDL-C, and lipid ratios, in a Libyan cohort of T2DM patients. In this retrospective cross-sectional study, 363 T2DM patients (140 males, 223 females) aged 18 to 80 years attending a diabetic polyclinic in Benghazi between January 2022 and January 2024 were included. Clinical and biochemical data, including fasting lipid profiles and glycated hemoglobin (HbA1c), were extracted from patient records. Participants were classified according to glycemic control (HbA1c\u2005&lt;\u20057% vs \u22657%). Associations between lipid parameters, lipid ratios, and glycemic control were assessed using multivariable logistic regression adjusted for age, sex, BMI, duration of diabetes, and statin use. Patients with uncontrolled HbA1c (\u22657%) had significantly higher TG\/HDL-C ratios (3.79\u2005\u00b1\u20052.52 vs 2.92\u2005\u00b1\u20052.42;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u2005.007) and LDL-C\/HDL-C ratios (2.55\u2005\u00b1\u20051.30 vs 1.95\u2005\u00b1\u20051.05;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&lt;\u2005.001) compared with those with controlled HbA1c. In multivariable logistic regression analysis, higher low-density lipoprotein cholesterol (LDL-C) levels were significantly associated with uncontrolled HbA1c (OR\u2005=\u20051.02; 95% CI: 1.01\u20131.03;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&lt;\u2005.001). When lipid ratios were evaluated, the LDL-C\/HDL-C ratio remained significantly associated with uncontrolled HbA1c (OR\u2005=\u20051.05; 95% CI: 1.02\u20131.09;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u2005.003). Lipid ratios, particularly LDL-C\/HDL-C, were associated with poor glycemic control in type 2 diabetes mellitus; however, their clinical utility requires further validation in prospective studies. Integrated management of dyslipidemia and glycemic control is essential to reduce cardiovascular complications in this population.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000049337","type":"journal-article","created":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T06:01:44Z","timestamp":1782108104000},"page":"e49337","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Association of triglyceride to high-density lipoprotein cholesterol and low-density lipoprotein to high-density lipoprotein cholesterol ratios with glycemic control in type 2 diabetes mellitus: A cross-sectional study from a Libyan clinical cohort"],"prefix":"10.1097","volume":"105","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-4715-1244","authenticated-orcid":false,"given":"Sahar H.","family":"Mahmoud","sequence":"first","affiliation":[{"name":"Department of Physiology, Faculty of Medicine, Benghazi University, Benghazi, Libya"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatma R.","family":"Elfargani","sequence":"additional","affiliation":[{"name":"Department of Physiology, Faculty of Medicine, Benghazi University, Benghazi, Libya"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nagwa","family":"Mohamed","sequence":"additional","affiliation":[{"name":"Department of Physiology, Faculty of Medicine, Benghazi University, Benghazi, Libya"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yousef","family":"Khader","sequence":"additional","affiliation":[{"name":"Department of Public Health, Faculty of Medicine, Jordan University of Science and Technology, Irbid, Jordan."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20261113","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s11886-021-01455-w","article-title":"Mechanisms and treatment of dyslipidemia in diabetes.","volume":"23","author":"Bahiru","year":"2021","journal-title":"Curr Cardiol Rep"},{"key":"R2-20261113","first-page":"150","article-title":"Dyslipidemia in type 2 diabetes mellitus.","volume":"5","author":"Mooradian","year":"2009","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"R3-20261113","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1210\/jcem.86.3.7304","article-title":"Clinical review 124: diabetic dyslipidemia: causes and consequences.","volume":"86","author":"Goldberg","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"R4-20261113","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s00125-003-1111-y","article-title":"Diabetic dyslipidaemia: from basic research to clinical practice.","volume":"46","author":"Taskinen","year":"2003","journal-title":"Diabetologia"},{"key":"R5-20261113","doi-asserted-by":"crossref","first-page":"3700","DOI":"10.4103\/jfmpc.jfmpc_165_21","article-title":"TG\/HDL ratio: a marker for insulin resistance and atherosclerosis in prediabetics or not?","volume":"10","author":"Chauhan","year":"2021","journal-title":"J Family Med Prim Care"},{"key":"R6-20261113","first-page":"163","article-title":"The Triglyceride\/HDL ratio and triglyceride glucose index as predictors of glycemic control in patients with diabetes mellitus type 2.","volume":"73","author":"Babic","year":"2019","journal-title":"Med Arch"},{"key":"R7-20261113","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/labmed\/lmae052","article-title":"Association between triglyceride to HDL cholesterol ratio and a risk of diabetes mellitus: a systematic review and meta-analysis.","volume":"56","author":"Zhong","year":"2025","journal-title":"Lab. Med"},{"key":"R8-20261113","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1186\/s12933-023-02046-5","article-title":"Triglycerides\/HDL cholesterol ratio and type 2 diabetes incidence: panasonic cohort study 10.","volume":"22","author":"Yuge","year":"2023","journal-title":"Cardiovasc Diabetol"},{"key":"R9-20261113","first-page":"e53665","article-title":"Lipoprotein ratios: correlations with glycated hemoglobin among type 2 diabetes mellitus patients.","volume":"16","author":"Lnu","year":"2024","journal-title":"Cureus"},{"key":"R10-20261113","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1007\/s00125-014-3374-x","article-title":"Statins and glycaemic control in individuals with diabetes: a systematic review and meta-analysis.","volume":"57","author":"Erqou","year":"2014","journal-title":"Diabetologia"},{"key":"R11-20261113","doi-asserted-by":"crossref","first-page":"175672","DOI":"10.1016\/j.ejphar.2023.175672","article-title":"Effects of statin therapy on glycemic control and insulin resistance: A systematic review and meta-analysis.","volume":"947","author":"Alvarez-Jimenez","year":"2023","journal-title":"Eur J Pharmacol"},{"key":"R12-20261113","first-page":"17","article-title":"The prevalence of dyslipidemia among type 2 diabetes mellitus patients in Al-khums Diabetic Center-Libya.","volume":"13","author":"Alasga","year":"2024","journal-title":"\u0645\u062c\u0644\u0629 \u0627\u0644\u0628\u062d\u0648\u062b \u0627\u0644\u0623\u0643\u0627\u062f\u064a\u0645\u064a\u0629"},{"key":"R13-20261113","first-page":"316","article-title":"Evaluation of glycemic and lipid profiles among patients with type 2 diabetes mellitus in Derna City - Libya.","volume":"3","author":"Khagkhag","year":"2025","journal-title":"Wadi Alshatti Univ J Pure Appl Sci"},{"key":"R14-20261113","article-title":"Introduction and methodology: standards of care in diabetes-2024.","volume":"47","year":"2024","journal-title":"Diabetes Care"},{"key":"R15-20261113","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1111\/j.1523-1755.2005.00365.x","article-title":"Definition and classification of chronic kidney disease: a position statement from kidney disease: improving global outcomes (KDIGO).","volume":"67","author":"Levey","year":"2005","journal-title":"Kidney Int"},{"key":"R16-20261113","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s12291-012-0225-8","article-title":"Dyslipidemia associated with poor glycemic control in type 2 diabetes mellitus and the protective effect of metformin supplementation.","volume":"27","author":"Mullugeta","year":"2012","journal-title":"Indian J Clin Biochem"},{"key":"R17-20261113","doi-asserted-by":"crossref","first-page":"154","DOI":"10.3390\/diseases11040154","article-title":"Correlation of HbA1c level with lipid profile in type 2 diabetes mellitus patients visiting a primary healthcare center in Jeddah City, Saudi Arabia: a retrospective cross-sectional study.","volume":"11","author":"Sharahili","year":"2023","journal-title":"Diseases"},{"key":"R18-20261113","doi-asserted-by":"crossref","first-page":"149","DOI":"10.2147\/VHRM.S209830","article-title":"High level of individual lipid profile and lipid ratio as a predictive marker of poor glycemic control in type-2 diabetes mellitus.","volume":"15","author":"Artha","year":"2019","journal-title":"Vasc Health Risk Manag"},{"key":"R19-20261113","doi-asserted-by":"crossref","first-page":"e0116110","DOI":"10.1371\/journal.pone.0116110","article-title":"Association between lipid ratios and insulin resistance in a Chinese population.","volume":"10","author":"Zhang","year":"2015","journal-title":"PLoS One"},{"key":"R20-20261113","doi-asserted-by":"crossref","first-page":"807","DOI":"10.3390\/metabo11120807","article-title":"The reciprocal relationship between LDL metabolism and type 2 diabetes mellitus.","volume":"11","author":"Bonilha","year":"2021","journal-title":"Metabolites"},{"key":"R21-20261113","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/S0002-9149(03)00611-8","article-title":"Role of endothelial dysfunction in insulin resistance.","volume":"92","author":"Hsueh","year":"2003","journal-title":"Am J Cardiol"},{"key":"R22-20261113","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.2147\/DMSO.S518509","article-title":"Association between triglyceride to high-density lipoprotein cholesterol ratio and insulin resistance in Mongolian adults.","volume":"18","author":"Narkhajid","year":"2025","journal-title":"Diabetes Metab Syndr Obes"},{"key":"R23-20261113","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1097\/MED.0000000000000241","article-title":"Triglycerides to high-density lipoprotein-cholesterol ratio, glycemic control and cardiovascular risk in obese patients with type 2 diabetes.","volume":"23","author":"Quispe","year":"2016","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"R24-20261113","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s13098-023-00988-0","article-title":"Association of triglycerides to high-density lipoprotein cholesterol ratio to identify future prediabetes and type 2 diabetes mellitus: over one-decade follow-up in the Iranian population.","volume":"15","author":"Tohidi","year":"2023","journal-title":"Diabetol Metab Syndr"},{"key":"R25-20261113","doi-asserted-by":"crossref","first-page":"1442731","DOI":"10.3389\/fendo.2024.1442731","article-title":"Triglyceride to high-density lipoprotein cholesterol ratio is associated with diabetes incidence in non-obese individuals with normoglycemia: a retrospective cohort study based on individuals from East Asia.","volume":"15","author":"Huang","year":"2024","journal-title":"Front Endocrinol (Lausanne)"},{"key":"R26-20261113","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1517\/14656566.2013.810210","article-title":"Statin therapy on glycaemic control in type 2 diabetes: a meta-analysis.","volume":"14","author":"Zhou","year":"2013","journal-title":"Expert Opin Pharmacother"},{"key":"R27-20261113","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/1758-5996-6-53","article-title":"Statins use is associated with poorer glycaemic control in a cohort of hypertensive patients with diabetes and without diabetes.","volume":"6","author":"Liew","year":"2014","journal-title":"Diabetol Metab Syndr"},{"key":"R28-20261113","doi-asserted-by":"crossref","first-page":"e000369","DOI":"10.1136\/bmjdrc-2016-000369","article-title":"Obesity paradox and mortality in adults with and without incident type 2 diabetes: a matched population-level cohort study.","volume":"5","author":"Badrick","year":"2017","journal-title":"BMJ Open Diabetes Res Care"},{"key":"R29-20261113","doi-asserted-by":"crossref","first-page":"61","DOI":"10.4103\/0019-5359.121117","article-title":"Responses to glycemic control therapy according to age, gender, level of adiposity, and duration of diabetes in type 2 diabetic patients.","volume":"67","author":"Ewenighi","year":"2013","journal-title":"Indian J Med Sci"},{"key":"R30-20261113","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.3923\/pjbs.2020.1643.1649","article-title":"Impact of gender on type II diabetes glycemic and cardiovascular markers control and treatment.","volume":"23","author":"Alswat","year":"2020","journal-title":"Pak J Biol Sci"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000049337","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T16:04:18Z","timestamp":1794585858000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000049337"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,19]]},"references-count":30,"journal-issue":{"issue":"25","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000049337","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,19]]},"assertion":[{"value":"2026-03-12","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-29","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}